• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Data Market
    Data News
    Data Stocks
    • Data Market
    • Data News
    • Data Stocks

    BIO-key International Completes Conversion of all Outstanding Preferred Stock into Common Stock

    Bala Yogesh
    Jun. 04, 2018 09:24AM PST
    Data Investing

    BIO-key International Inc (NASDAQ:BKYI), a provider of biometric authentication and security solutions announced that all remaining outstanding shares of the company’s Series A-1 and Series B-1 convertible preferred stock and all accrued and unpaid dividends have been converted into common stock at a conversion price of $3.60 per share. As quoted in the press release: …

    BIO-key International Inc (NASDAQ:BKYI), a provider of biometric authentication and security solutions announced that all remaining outstanding shares of the company’s Series A-1 and Series B-1 convertible preferred stock and all accrued and unpaid dividends have been converted into common stock at a conversion price of $3.60 per share.

    As quoted in the press release:

    As a result of these conversions and other preferred stock conversions earlier in 2018, BIO-key has eliminated approximately $638,000 in future annual preferred stock dividends payments. Additionally, BIO-key has satisfied payment of all accrued preferred stock dividends through the issuance of common stock at a price of $3.60 per share.

    In 2018, BIO-key has paid $828,441 in accrued preferred stock dividends through the issuance of 230,123 shares of its Common stock. Reflecting the preferred stock conversions and accrued dividend payments in 2018, BIO-key has issued 4,885,569 shares of common stock, increasing its total issued and outstanding shares to 12.6 million.

    BIO-key’s CEO Michael DePasquale commented, “We are grateful for the support and confidence of these long-term investors who converted preferred stock and accrued dividends into common stock at roughly a 61% premium to the Friday June 1st closing price of $2.23. The conversions simplify and strengthen BIO-key’s capital structure while eliminating all future dividend payment requirements.”

    Year to Date Conversions of Convertible Preferred Stock and Accrued Dividends

    Preferred
    Shares
    Converted to
    Common
    Accrued
    Dividends
    Converted into
    Common
    Conversion
    Price
    Common
    Shares
    Issued
    DateReduction in
    Annual
    Dividends
    Series B-1 2.5% Convertible Preferred60,420$3.601,678,3343/23/2018$  151,050
    Accrued Series B-1 dividends$417,084$3.60115,8573/23/2018
    Series B-1 2.5% Convertible Preferred44,580$3.601,238,3345/23/2018$  111,450
    Accrued Series B-1 dividends$55,342$3.6015,3735/23/2018
    Series A-1 6% Convertible Preferred39,088$3.601,085,7784/3/2018$  234,528
    Accrued A-1 dividends$330,552$3.6091,8204/3/2018
    Series A-1 6% Convertible Preferred23,508$3.60653,0005/31/2018$  141,048
    Accrued A-1 dividends$25,463$3.607,0735/31/2018
    Totals$828,4414,885,569$  638,076

     

    Click here for the full text release.

    The Conversation (0)

    Go Deeper

    AI Powered
    Merck Announces First-Quarter 2023 Financial Results

    Merck Announces First-Quarter 2023 Financial Results

    Generation Mining Announces Feasibility Study Report Update for the Marathon Copper-Palladium Project

    Generation Mining Announces Feasibility Study Report Update for the Marathon Copper-Palladium Project

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Data Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×